Cholangiocarcinoma News and Research

RSS
Scientists identify new driver for rare type of liver cancer

Scientists identify new driver for rare type of liver cancer

Potential applications of bioactive molecules present in fruit peels

Potential applications of bioactive molecules present in fruit peels

New study reveals oral opaganib's potent in vitro activity against Omicron

New study reveals oral opaganib's potent in vitro activity against Omicron

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Using interdisciplinary approach to beat cancer

Using interdisciplinary approach to beat cancer

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

ASTRO provides new guidance on the use of external beam radiation therapy for primary liver cancers

Washington University School of Medicine receives $17 million to address disparities in cancers

Washington University School of Medicine receives $17 million to address disparities in cancers

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

Scientists turn into molecular detectives to find clues to why certain cancer therapies stop working

Study identifies actionable genes and candidate drugs in biliary tract cancer using a knowledgebase

Study identifies actionable genes and candidate drugs in biliary tract cancer using a knowledgebase

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Antagonism of glucocorticoid receptors promotes apoptosis in solid tumor cells

Antagonism of glucocorticoid receptors promotes apoptosis in solid tumor cells

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

SWOG researchers to present practice-changing research at virtual ASCO 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

AMSBIO's custom lentivectors for labeling organoids

AMSBIO's custom lentivectors for labeling organoids

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

AACR and MPM award three grants to support groundbreaking cancer research projects

AACR and MPM award three grants to support groundbreaking cancer research projects